Prilocaine or Bupivacaine for Spinal Anesthesiain Pregnant (Césarcaïne)

December 10, 2018 updated by: University Hospital, Montpellier

Comparison of the Duration of Motor Block After Spinal Anesthesia for Planned Cesarean Sections: Hyperbaric Prilocaïne Versus Hyperbaric Bupivacaine

The planned cesarean section is an intervention with a standard operating time of less than 40 minutes in trained teams. Hyperbaric Bupivacaine is the local anesthetic (LA) reference for these operations. But the duration of its motor block is generally greater than 3 hours. The purpose of this study is to show a reduction in motor block time with hyperbaric Prilocaine by at least 30 minutes, which would allow mothers and their children to return to the maternity ward earlier and thus improve the circulation of patients within the maternity's PACU.

Study Overview

Status

Unknown

Conditions

Intervention / Treatment

Detailed Description

Prospective study, randomized into two parallel groups (Hyperbaric Prilocaïne versus hyperbaric Bupivacaine), double-blind, monocentric (Clinique Saint Roch in Montpellier).

The number of subjects required is 50 patients, 25 per group.

Study Type

Interventional

Enrollment (Anticipated)

50

Phase

  • Phase 2

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Normal pregnancy
  • Scheduled caesarean section
  • Non-multiple pregnancy
  • Age of patient: 18 years and over
  • Height of patient: between 155 and 175 cm
  • Affiliated patients or beneficiaries of a Social Security System
  • Signature of the patient's consent

Exclusion criteria:

  • Patient <18 years
  • Pathological pregnancy
  • Multiple pregnancy
  • Emergency caesarean
  • Patients who cannot give informed consent (not French speaking)
  • Refusal of the patient
  • Contraindications to spinal anesthesia
  • Contraindications to Prilocaine
  • Contraindications to Bupivacaine

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Hyperbaric Bupivacaine
spinal anesthesia for planned cesarean sections control group
spinal anesthesia for planned cesarean sections
Active Comparator: Hyperbaric Prilocaïne
spinal anesthesia for planned cesarean sections
spinal anesthesia for planned cesarean sections

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
duration of motor block
Time Frame: up to 6 hours
To compare the duration of motor block after spinal anesthesia with hyperbaric Prilocaïne versus hyperbaric Bupivacaine This evaluation is done every 15 min from the entrance to the recovery room (PACU); the motor block stops being evaluated when the modified bromination score reaches 4
up to 6 hours

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The upper sensory level
Time Frame: 15 minutes after the LA injection
The upper sensory level obtained 15 minutes after the LA injection
15 minutes after the LA injection
Hypotensive episodes
Time Frame: 1 day
Hypotensive episodes
1 day
The time between injection and incision
Time Frame: 1 day
The time between injection and incision
1 day
The duration of the intervention
Time Frame: 1 day
The duration of the intervention
1 day
The time to return to the standard maternity ward
Time Frame: 1 day
The time to return to the standard maternity ward
1 day
APGAR score of newborns at birth
Time Frame: 1 day

APGAR score of newborns at birth. L'APGAR Apgar score is a method to quickly summarize the health of newborn children.

The Apgar scale is determined by evaluating the newborn baby on five simple criteria on a scale from zero to two, then summing up the five values thus obtained. The resulting Apgar score ranges from zero to 10. The five criteria are summarized using words chosen to form a backronym (Appearance, Pulse, Grimace, Activity, Respiration).

The test is generally done at one and five minutes after birth, and may be repeated later if the score is and remains low. Scores 7 and above are generally normal, 4 to 6 fairly low, and 3 and below are generally regarded as critically low.

1 day
The delay between spinal anesthesia and the first emergency analgesic injection
Time Frame: 1 day
The delay between spinal anesthesia and the first emergency analgesic injection
1 day
Assessment of pain (VAS)
Time Frame: 1 day
Pain on arrival and departure of PACU and at 24 hours. Pain will be assessedby VAS (Visual Analogue Scale); Patients rate pain on VAS from 0-10, 0 being no pain and 10 being the worst pain imaginable..
1 day
The delay between spinal anesthesia and the first injection of second-line analgesia
Time Frame: 1 day
The delay between spinal anesthesia and the first injection of second-line analgesia : delay between spinal anesthesia ans the need of rescue analgesia
1 day
The presence of neuro-sensory disorders within 24 hours postoperatively
Time Frame: 1 day
The presence of neuro-sensory disorders within 24 hours postoperatively
1 day
The presence of post lumbar puncture syndrome
Time Frame: 1 day
The presence of post lumbar puncture syndrome
1 day
score de satisfaction
Time Frame: 1 day
Patient satisfaction score at 24 hours will be assessed by VAS (Visual Analogue Scale); Patients rate satisfaction on VAS from 0-10, 0 being no satisfaction and 10 being total satisfaction
1 day
Statifaction of the Surgeon
Time Frame: 1 day
The surgeon assessed his satisfaction while the cesarien section. The surgeon satisfaction score at 24 hours will be assessed by VAS (Visual Analogue Scale); Surgeon rate satisfaction on VAS from 0-10, 0 being no satisfaction and 10 being total satisfaction.
1 day

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: christophe DADURE, University Hospital, Montpellier

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 7, 2018

Primary Completion (Anticipated)

May 7, 2020

Study Completion (Anticipated)

August 30, 2020

Study Registration Dates

First Submitted

December 21, 2017

First Submitted That Met QC Criteria

February 8, 2018

First Posted (Actual)

February 15, 2018

Study Record Updates

Last Update Posted (Actual)

December 11, 2018

Last Update Submitted That Met QC Criteria

December 10, 2018

Last Verified

March 1, 2018

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

IPD Plan Description

NC

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cesarean

Clinical Trials on spinal anesthesia

3
Subscribe